These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 23350965

  • 21. The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection.
    Katz MD, Serrano MF, Humphrey PA, Grubb RL, Skolarus TA, Gao F, Kibel AS.
    Urol Oncol; 2011; 29(6):738-44. PubMed ID: 19914106
    [Abstract] [Full Text] [Related]

  • 22. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
    Iimura Y, Kihara K, Saito K, Masuda H, Kobayashi T, Kawakami S.
    Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
    [Abstract] [Full Text] [Related]

  • 23. Microvascular tumor invasion: prognostic significance in low-stage renal cell carcinoma.
    Madbouly K, Al-Qahtani SM, Ghazwani Y, Al-Shaibani S, Mansi MK.
    Urology; 2007 Apr; 69(4):670-4. PubMed ID: 17445649
    [Abstract] [Full Text] [Related]

  • 24. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
    Beemster PW, Barwari K, Mamoulakis C, Wijkstra H, de la Rosette JJ, Laguna MP.
    BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
    [Abstract] [Full Text] [Related]

  • 25. Microscopic venous invasion is associated with disease free and cancer free survival in renal cell carcinoma.
    Sanli O, Zorba OU, Erdem S, Tezer M, Kilicar-Slan I, Esen T, Tunc M.
    Minerva Urol Nefrol; 2010 Dec; 62(4):347-53. PubMed ID: 20944535
    [Abstract] [Full Text] [Related]

  • 26. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
    Takagi T, Kondo T, Izuka J, Kobayashi H, Tomita E, Hashimoto Y, Tanabe K.
    Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
    [Abstract] [Full Text] [Related]

  • 27. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH, You D, Jeong IG, Kwon TW, Cho YM, Hong JH, Ahn H, Kim CS.
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.
    May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, Gunia S.
    Urol Oncol; 2010 Dec; 28(3):274-9. PubMed ID: 18805709
    [Abstract] [Full Text] [Related]

  • 29. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R, Roscigno M, Freschi M, Strada E, Angiolilli D, Petralia G, Matloob R, Sozzi F, Capitanio U, Da Pozzo LF, Colombo R, Guazzoni G, Cremonini A, Montorsi F, Rigatti P.
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S, Vander Eeckt K, Srirangam SJ, Van Poppel H.
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [Abstract] [Full Text] [Related]

  • 32. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
    Belsante M, Darwish O, Youssef R, Bagrodia A, Kapur P, Sagalowsky AI, Lotan Y, Margulis V.
    Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
    [Abstract] [Full Text] [Related]

  • 33. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A, Kurosch M, Pritsch M, Hatiboglu G, Macher-Goeppinger S, Pfitzenmaier J, Pahernik S, Wagener N, Hohenfellner M.
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [Abstract] [Full Text] [Related]

  • 34. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M, Minervini A, Lapini A, Masieri L, Serni S.
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [Abstract] [Full Text] [Related]

  • 35. Prognostic role of tumour multifocality in renal cell carcinoma.
    Siracusano S, Novara G, Antonelli A, Artibani W, Bertini R, Carini M, Carmignani G, Ciciliato S, Cunico SC, Lampropoulou N, Longo N, Martorana G, Minervini A, Mirone V, Simeone C, Simonato A, Valotto C, Zattoni F, Ficarra V, members of the SATURN Project - LUNA Foundation.
    BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
    [Abstract] [Full Text] [Related]

  • 36. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L, Patard JJ, Chiodini P, Schips L, Ficarra V, Tostain J, de La Taille A, Altieri V, Lobel B, Zigeuner RE, Artibani W, Guillé F, Abbou CC, Salzano L, Gallo C.
    Cancer; 2005 Oct 01; 104(7):1362-71. PubMed ID: 16116599
    [Abstract] [Full Text] [Related]

  • 37. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
    Ficarra V, Novara G, Galfano A, Novella G, Schiavone D, Artibani W.
    Urology; 2004 Jun 01; 63(6):1050-4. PubMed ID: 15183948
    [Abstract] [Full Text] [Related]

  • 38. Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma.
    Minervini A, Serni S, Tuccio A, Siena G, Vittori G, Masieri L, Giancane S, Lanciotti M, Khorrami S, Lapini A, Carini M.
    Ann Surg Oncol; 2012 Feb 01; 19(2):694-700. PubMed ID: 21861225
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
    Hellenthal NJ, Mansour AM, Hayn MH, Schwaab T.
    Urol Oncol; 2013 Jan 01; 31(1):36-41. PubMed ID: 21396834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.